logo

Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full arti[...]
For the first time, Storebjerg et al. [1] describe the prevalence of the HOXB13 G84E mutation in a Danish population and its association with prostate cancer risk and features indi[...]
Every week the Editor-in-Chief selects the Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]
In the 19th century Lord Kelvin wrote, ‘If you cannot measure it, you cannot improve it’. Since then clinical improvement has often been about measuring outcomes to determine what [...]
Using Patient-Reported Outcomes to Assess and Improve Prostate Cancer Brachytherapy James A. Talcott 1, 2, 10, 11, Judith Manola 3, Ronald C. Chen 4, Jack A. Clark 5, 6, Irving Kap[...]
Every week the Editor-in-Chief selects the Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]
Robert Pickard and Luke Vale Governments of all nations struggle to work out how best to use the limited resources available for health care. One key area of uncertainty is long te[...]
        Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis Matthew R. Cooperberg, Naren R. Ramakrishna†[...]